Shinsuke Ishigaki

Title: Shinsuke Ishigaki: Innovator in Antisense Oligonucleotide Technology

Introduction

Shinsuke Ishigaki is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotides. His work focuses on controlling the expression of TDP-43, a protein associated with various neurodegenerative diseases.

Latest Patents

Ishigaki holds a patent for an antisense oligonucleotide that targets TDP-43 mRNA. This invention provides a suppression-type antisense oligonucleotide containing a nucleotide sequence complementary to a sequence of at least 10 continuous nucleotides in specific nucleotide sequences. Additionally, it includes a promotion-type antisense oligonucleotide targeting TDP-43 mRNA, which also contains a complementary nucleotide sequence.

Career Highlights

Throughout his career, Shinsuke Ishigaki has worked with prestigious institutions such as Osaka University and Knc Laboratories Co., Ltd. His research has contributed to advancements in understanding the role of TDP-43 in cellular processes and its implications in disease.

Collaborations

Ishigaki has collaborated with notable colleagues, including Yoshitaka Nagai and Kazuhiro Maeta. These partnerships have enhanced his research and expanded the impact of his inventions.

Conclusion

Shinsuke Ishigaki's innovative work in antisense oligonucleotide technology represents a significant advancement in molecular biology. His contributions continue to influence research in neurodegenerative diseases and therapeutic development.